Editorial

From the desk of the editor

Welcome to the May 2012 homepage edition of i2P-Information to Pharmacists. Rollo Manning has been having some time out having staples removed from the site of his open heart surgery.He is now at home recuperating in Darwin, having arrived home last Friday, beating a cold and hasty retreat from Canberra.We all wish him a speedy recovery and hopefully, he will be fit enough to contribute by next month.
This month, Pharmedia discusses the toll that is taken when someone complains about you to an authority without good cause. Well, the good news is that you can now take action to protect yourself if such a complaint is made, and that may even include action for defamation. Read about a recent case involving two doctors, with Mark Coleman drawing on personal experience to illustrate.

read more
open full screen

Columns

Recent Comments

Click here to read...

Past Editions

Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4

i2P Archives

EPublications

Click here for a list of epublications

Fatty Liver Helped by Berries in Diet

• Printer-friendly version
• Send to friend
• PDF version
• Share

	Staff Writer articles by this author...
Editing and Researching news and stories about global and local Pharmacy Issues

A diet rich in berries may reduce levels of inflammatory markers associated with liver health and metabolic syndrome, says a new study from Finland.
Daily consumption of a range of berries, including lingonberry, sea buckthorn, bilberry, and black currant produced a 23 per cent reduction in levels of an enzyme called alanine aminotransferase (ALAT), a well-established marker of nonalcoholic fatty liver disease (NAFLD), according to findings published in the European Journal of Clinical Nutrition.

open this article full screen

Fatty liver is reportedly on the rise in the US, with between one quarter and one half of Americans, and the prevalence of NAFLD has increased in line with the ongoing obesity epidemic.

Recent findings have also reported that metabolic syndrome, a condition characterised by central obesity, hypertension, and disturbed glucose and insulin metabolism, and linked to increased risks of both type 2 diabetes and CVD, does not develop at all without NAFLD.

The new study, led by Dr Heikki Kallio from the Department of Biochemistry and Food Chemistry at the University of Turku , is said to be the first human trial linking berries to liver function and components of metabolic syndrome.

Kallio and his co-workers recruited 31 women with an average age of 43 and randomly assigned them to one of two groups: Both groups underwent a lifestyle intervention, and one group received a supplement of 163 grams per day of lingonberry (Vaccinium vitis-idaea), sea buckthorn berry (Hippophae rhamnoides, ssp. mongolica, var. Ljubitelskaja), bilberry (V. myrtillus) and black currant (Ribes nigrum). Berries were supplied as food products and intended to replace other snacks. Five Finnish food enterprises manufactured the products, noted the researchers

At the end of 20 weeks, ALAT levels decreased by 23 per cent in the berry group, which the researchers said could be regarded as “nutritionally significant by enhancing the liver function”.

Clinical Newsfeed

Click here to read more...

Research Reports

Practice Development

Information Technology

Preventive Medicine

i2P Alliance Partners